ESBATech Hires CFO and Director of Preclinical Development
ESBATech Hires CFO and Director of Preclinical Development
About this item
Full title
ESBATech Hires CFO and Director of Preclinical Development
Publisher
New York: PR Newswire Association LLC
Journal title
PR Newswire, 2005, p.1
Language
English
Formats
Publication information
Publisher
New York: PR Newswire Association LLC
Subjects
More information
Scope and Contents
Contents
ESBATech AG focuses on therapeutic applications of its proprietary, fully human antibody fragments. The Company has developed a proprietary procedure for the selection of highly stable, fully human antibody fragments. This selection procedure was successfully applied and identified naturally occurring and highly stable human antibody fragments. The...
Alternative Titles
Full title
ESBATech Hires CFO and Director of Preclinical Development
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_451559782
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_451559782
How to access this item
Log in as a Library member
